D R Rubinow
Overview
Explore the profile of D R Rubinow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
2924
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walsh E, Prim J, Gibson K, Hynd M, Phillips R, Dichter G, et al.
J Affect Disord
. 2025 Jan;
378:340-349.
PMID: 39837465
Background: Half of perimenopausal women experience depressive symptoms, including anhedonia. Anhedonia is associated with dysregulation of the frontostriatal circuit. Both the frontrostriatal circuit and depression may be regulated by the...
2.
Schiller C, Walsh E, Eisenlohr-Moul T, Prim J, Dichter G, Schiff L, et al.
J Affect Disord
. 2022 Jul;
314:176-184.
PMID: 35777494
Background: Reward system dysfunction is evident across neuropsychiatric conditions. Here we present data from a double-blinded pharmaco-fMRI study investigating the triggering of anhedonia and reward circuit activity in women. Methods:...
3.
Guintivano J, Sullivan P, Stuebe A, Penders T, Thorp J, Rubinow D, et al.
Psychol Med
. 2017 Sep;
48(7):1190-1200.
PMID: 28950923
Background: Race, psychiatric history, and adverse life events have all been independently associated with postpartum depression (PPD). However, the role these play together in Black and Latina women remains inadequately...
4.
Nguyen T, Reuter J, Gaikwad N, Rotroff D, Kucera H, Motsinger-Reif A, et al.
Transl Psychiatry
. 2017 Aug;
7(8):e1193.
PMID: 28786978
Clinical evidence suggests that symptoms in premenstrual dysphoric disorder (PMDD) reflect abnormal responsivity to ovarian steroids. This differential steroid sensitivity could be underpinned by abnormal processing of the steroid signal....
5.
Wei S, Baller E, Kohn P, Kippenhan J, Kolachana B, Soldin S, et al.
Mol Psychiatry
. 2017 Apr;
23(4):1066-1075.
PMID: 28416813
Preclinical evidence suggests that the actions of ovarian steroid hormones and brain-derived neurotrophic factor (BDNF) are highly convergent on brain function. Studies in humanized mice document an interaction between estrus...
6.
Schmalenberger K, Eisenlohr-Moul T, Surana P, Rubinow D, Girdler S
Psychol Med
. 2017 Feb;
47(9):1585-1596.
PMID: 28193300
Background: Women who experience significant premenstrual symptoms differ in the extent to which these symptoms cause cyclical impairment. This study clarifies the type and number of symptoms that best predict...
7.
Dubey N, Hoffman J, Schuebel K, Yuan Q, Martinez P, Nieman L, et al.
Mol Psychiatry
. 2017 Jan;
22(8):1172-1184.
PMID: 28044059
Clinical evidence suggests that mood and behavioral symptoms in premenstrual dysphoric disorder (PMDD), a common, recently recognized, psychiatric condition among women, reflect abnormal responsivity to ovarian steroids. This differential sensitivity...
8.
Di Florio A, Putnam K, Altemus M, Apter G, Bergink V, Bilszta J, et al.
Psychol Med
. 2016 Nov;
47(5):787-799.
PMID: 27866476
Background: Universal screening for postpartum depression is recommended in many countries. Knowledge of whether the disclosure of depressive symptoms in the postpartum period differs across cultures could improve detection and...
9.
10.
Rubinow D, Cancro R
J Youth Adolesc
. 2014 Jan;
6(1):1-9.
PMID: 24408228
Results are presented of a self-administered questionnaire completed by 201 youthful hallucinogen users. It was found that 55.5% of the population experienced at least one bad trip, although not one...